Defiance Hotel, Airline, and Cruise ETF (ARCA: CRUZ)

에 대한 최신 뉴스 Defiance Hotel, Airline, and Cruise ETF (ARCA:CRUZ)

Consumer Cyclical

Industrials

Real Estate

The Fund will generally use a replication strategy to achieve its investment objective, meaning the Fund will generally invest in all of the component securities of the Index in the same approximate proportions as in the Index. However, the Fund may use a representative sampling strategy, meaning it may invest in a sample of the securities in the Index whose risk, return, and other characteristics closely resemble the risk, return, and other characteristics of the Index as a whole, when the Funds sub-adviser believes it is in the best interests of the Fund (e.g., when replicating the Index involves practical difficulties or substantial costs, an Index constituent becomes temporarily illiquid, unavailable, or less liquid, or as a result of legal restrictions or limitations that apply to the Fund but not to the Index).

Hilton Worldwide Holdings, Inc.

Marriott International, Inc.

Royal Caribbean Cruises Ltd.

Delta Air Lines Inc.

Carnival Corp.

Ryanair Holdings Plc

Intercontinental Hotels Group Plc, Adr

United Airlines Holdings Inc.

Southwest Airlines Co.

Host Hotels & Resorts Inc.

Defiance Hotel Airline and Cruise ETF

Analyst Color

Equities

Large Cap

News

Analyst Ratings

Trading Ideas

CRUZ

PowerShares ETF Leisure & Entertainment Port

로얄 캐리비안 크루즈(NYSE:RCL)의 주가가 화요일에 혼재된 3분기 실적을 발표 후 3% 이상 상승했다. 매출은 전년 대비 17.5% 증가한 48억 9천만 달러로, 컨센서스인 49억 달러를 밑돌았고, 조정된 주당순이익(EPS)은 5.20 달러로 컨센서스인 5.03 달러를 상회했다.

로얄 캐리비안의 3분기 EPS는 예상을 상회했지만, 골드만삭스는 4분기 비용에 대해 경고

Defiance Hotel, Airline, and Cruise ETF

CRUZ BATTERY METALS CORP by Cruz Battery Metals Corp.

Cruz Battery Metals Corp

Jefferies analyst Corey Tarlowe maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Buy and raises the price target from $90 to $100.

Price Target

Jefferies Maintains Buy on Walmart, Raises Price Target to $100

WIIM

ABAT

American Battery Technology shares are trading lower. The company reported Q1 financial results.

TD Cowen analyst Doug Creutz maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Hold and raises the price target from $108 to $123.

TD Cowen Maintains Hold on Walt Disney, Raises Price Target to $123

Jefferies analyst Samad Samana maintains NICE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) with a Buy and lowers the price target from $230 to $215.

NICE

Jefferies Maintains Buy on NICE, Lowers Price Target to $215

Goatseus Maximus (CRYPTO: GOAT) has seen impressive gains, climbing 35.3% over the past week. The rally places the AI meme coin at the forefront of the meme coin market, with traders <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41432283/move-over-dogecoin-shiba-inu-ai-meme-coin-goat-prints-over-3-million-in-profit-for-whale-t">anticipating further upside</a>. 
What Happened: The gain pushed its valuation to $1 billion placing it in the top ten of the meme coin board.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Goatseus Maximus (CRYPTO: GOAT)</td>
<td>&nbsp;$1.02</td>
<td>$1 Billion</td>
<td>&nbsp;+10.7%</td>
<td>&nbsp;+33%</td>
</tr>
<tr>
<td>Popcat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POPCAT</a>)</td>
<td> $1.67</td>
<td>$1.6 Billion</td>
<td>&nbsp;-5.9%</td>
<td>&nbsp;+9.9%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With prices picking up steam, crypto trader Lucky <a href="https://x.com/LuckyXBT__/status/1857396228939518186">sees</a> GOAT price action quite similar to painful Popcat price action before its own "bull run."
Crypto trader Aylo predicts a bullish trend for the meme coin.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Clear skies ahead for <a href="https://twitter.com/search?q=%24GOAT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$GOAT</a> Time to accelerate. <a href="https://t.co/dxX2iJi3FT">pic.twitter.com/dxX2iJi3FT</a>
&mdash; Aylo (@alpha_pls) <a href="https://twitter.com/alpha_pls/status/1857432408414364014?ref_src=twsrc%5Etfw">November 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Daan Crypto Trades <a href="https://x.com/DaanCrypto/status/1857424121669324907">sees</a> GOAT finally getting the breakout, saying the AI meme coin is showing resilience, with dips being quickly bought up, signaling strong support.
A breakout is <a href="https://x.com/DaanCrypto/status/1856996799669530793">anticipated</a> due to its bullish chart pattern. As a leader in the AI meme coin meta, GOAT still lacks a Binance spot listing, but such a development could further boost its momentum.
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41917072/dogecoin-is-the-best-trump-proxy-industry-expert-claims">Dogecoin Is The &#8216;Best Trump Proxy,&#8217; Industry Expert Claims</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$POPCAT

AI Meme Coin GOAT Joins $1 Billion Club—Can It Target The Likes Of Dogecoin, Shiba Inu?

<a href="https://www.theverge.com/2024/11/15/24296351/microsoft-azure-openai-adobe-meta-customers-notepad">https://www.theverge.com/2024/11/15/24296351/microsoft-azure-openai-adobe-meta-customers-notepad</a>
Microsoft has been turning its OpenAI deal into a big business. Earlier this year, much of its Azure OpenAI offering, which provides access to OpenAI's language models, was contingent on a single big spender: TikTok. But I've now seen a recent list of its top customers, and it's clear that Microsoft has managed to diversify the business with a selection of major clients spending more than $1 million per month on Azure OpenAI services.
The software giant has a running list of what it considers its top 10 customers for Azure OpenAI, and I'm told Adobe and Meta both spent more than $1 million on Microsoft's AI services in September alone to make the top 10 customer list. Both Adobe and Meta are primarily using Microsoft's provisioned output for access to OpenAI models, which provides dedicated model processing capacity rather than Microsoft's token-based offerings for text and image generation.
Meta and Adobe's use of Azure OpenAI still falls far behind TikTok owner ByteDance's, though. The Information reported earlier this year that TikTok was <a href="https://www.theverge.com/2024/7/31/24210667/microsoft-tiktok-ai-openai-customer">paying Microsoft almost $20 million</a> per month to access OpenAI's models, making up nearly a quarter of the revenue generated by Azure OpenAI at the time. ByteDance's spending on Azure OpenAI is now less than 15 percent of Microsoft's Azure OpenAI business, thanks in part to a more diverse amount of customer spending on Microsoft's AI services and ByteDance spending less.
 &nbsp;

ADBE

MSFT

Reported Earlier, 'Microsoft's Top AI Customers Include Adobe And Meta/ TikTok Is Still Microsoft's Top Azure OpenAI Customer, Though' - The Verge

TD Cowen analyst Bryan Bergin maintains Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Buy and raises the price target from $533 to $567.

TD Cowen Maintains Buy on Mastercard, Raises Price Target to $567

On Friday, Vir Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) announced end-of-treatment data from Part B of the MARCH Phase 2 study evaluating combinations of tobevibart and elebsiran, with or without pegylated interferon alfa (PEG-IFNα), in participants with <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42012383/vir-biotechnology-announces-positive-end-of-treatment-results-for-tobevibart-and-elebsiran-combina" rel="noreferrer noopener">chronic hepatitis B</a>.
Chronic hepatitis B (CHB) is a long-lasting, inflammatory liver disease caused by the hepatitis B virus (HBV).
The World Health Organization estimates that 254 million people live with CHB, and an estimated 1.1 million yearly deaths are associated with the disease.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/06/39192084/why-is-infectious-disease-focused-vir-biotechnology-stock-trading-higher-on-wednesday" rel="noreferrer noopener">Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?</a>
Participants in the trial received tobevibart and elebsiran alone (doublet regimen) or in combination with PEG-IFNα (triplet regimen).
The study demonstrated promising rates of hepatitis B surface antigen (HBsAg) loss (seroclearance) in participants with low baseline HBsAg (&lt;1000 IU/mL) in both combination regimens.
The doublet and triplet regimens resulted in HBsAg loss at the end of treatment in 39% (7/18) and 46% (5/11) of participants with baseline HBsAg&lt;1,000 IU/mL, respectively.
The proportion of participants with varying baseline HBsAg levels who achieved HBsAg loss at the end of treatment was 16% (8/51) for the doublet and 22% (6/27) for the triplet regimen.
The doublet regimen resulted in 50% (4/8) of participants achieving HBsAg loss and anti-HBs seroconversion.
All participants with HBsAg loss at the end of treatment who received the triplet regimen achieved anti-HBs seroconversion (100%, 6/6).
Participants with HBsAg seroclearance at the end of treatment who meet eligibility criteria will discontinue treatment. A functional cure assessment will occur 24 weeks after treatment discontinuation.
Mark Eisner, Executive Vice President and Chief Medical Officer, Vir Biotechnology, said, &#8220;We are encouraged by these results and eagerly anticipate the functional cure data in 2025, as it will be decisive for the next steps of clinical development.&#8221;
Price Action: VIR stock is down 7.50% at $7.99 at the last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42012040/bristol-myers-faces-renewed-67-billion-lawsuit-over-drug-approval-delays-amid-resolved-trustee-issue" target="_blank" rel="noreferrer noopener">Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue</a></li>
</ul>

Biotech

Health Care

Movers

General

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?

<a href="https://www.nyserda.ny.gov/About/Newsroom/2024-Announcements/2024-11-15-NYSERDA-Issues-Advanced-Nuclear-Technologies-Request-For-Information#:~:text=Through%20this%20RFI%2C%20NYSERDA%20seeks,at%20Governor%20Kathy%20Hochul's%20direction.">https://www.nyserda.ny.gov/About/Newsroom/2024-Announcements/2024-11-15-NYSERDA-Issues-Advanced-Nuclear-Technologies-Request-For-Information#:~:text=Through%20this%20RFI%2C%20NYSERDA%20seeks,at%20Governor%20Kathy%20Hochul's%20direction.</a>
The New York State Energy Research and Development Authority (NYSERDA) today announced the issuance of a Request for Information (RFI) to gauge market interest in activities to develop advanced nuclear energy technologies in New York State. Through this RFI, NYSERDA seeks to identify entities that are currently pursuing or interested in a potential role in advanced nuclear energy development. Responses will help inform next steps following the Future Energy Economy Summit held in September at Governor Kathy Hochul's direction. Today's announcement demonstrates the State's continued commitment to remain at the forefront of emerging technologies to support the advancement of renewable energy resources and foster continued economic development.
NYSERDA President and CEO Doreen M. Harris said, "As local, national and international companies pursue nuclear energy for their on-site energy needs and the federal government signals interest in investing in this resource, we recognize that now is the time to position New York to fully engage this new sector that can drive significant economic development. Understanding the status of potential opportunities through this RFI will enable us to begin developing strategic partnerships and initiatives for complementary resources that will ultimately support the increased deployment of renewables as we work toward a zero-emission grid of the future."
Entities encouraged to respond include:
<ul>
<li>stakeholders who may be considering advanced nuclear solutions, such as users of large electric loads, industrial heat, and hydrogen – both those already active in New York and those considering establishing operations in New York;</li>
<li>supply chain companies that could provide critical components for development of advanced nuclear energy projects in New York;</li>
<li>potential host communities for nuclear reactors or supply chain projects</li>
<li>workforce development and training entities;</li>
<li>nuclear generation project developers;</li>
<li>financing/funding entities; and</li>
<li>research and development entities including laboratories, universities and private entities.</li>
</ul>
Generation project consideration associated with this RFI is restricted to New York Independent System Operator (NYSISO) Control Area Load <a href="https://www.nyiso.com/documents/20142/1397960/nyca_zonemaps.pdf/8c3807e1-5bab-ab44-3c71-2c8e61b5748b">Zones A-F <img src="https://www.nyserda.ny.gov/-/media/Project/Common/General/Rest/new-window.gif" alt="Link opens in new window - close new window to return to this page." /></a> which encompasses the area of New York State north and west of the lower Hudson Valley. All other aspects of the request including energy consumers, supply chain, and workforce apply to all parts of New York State.
Responses are preferred by December 16, 2024, to inform future engagement opportunities and planning. Responses may be submitted through NYSERDA's <a href="https://nyserda.seamlessdocs.com/f/AdvancedNuclearRFI">online portal <img src="https://www.nyserda.ny.gov/-/media/Project/Common/General/Rest/new-window.gif" alt="Link opens in new window - close new window to return to this page." /></a>. To view the RFI, visit NYSERDA's <a href="https://www.nyserda.ny.gov/Funding-Opportunities/Current-Funding-Opportunities">website</a>. Technical questions regarding this RFI may be directed to <a href="mailto:NuclearRFI@nyserda.ny.gov">NuclearRFI@nyserda.ny.gov <img src="https://www.nyserda.ny.gov/-/media/Project/Common/General/Rest/new-window.gif" alt="Link opens in new window - close new window to return to this page." /></a>.
Separate from today's announcement, later this year, NYSERDA also anticipates releasing a Final Blueprint for Consideration of Advanced Nuclear Technologies which was informed through public comments collected on the <a href="https://www.nyserda.ny.gov/summit">Draft Blueprint <img src="https://www.nyserda.ny.gov/-/media/Project/Common/General/Rest/new-window.gif" alt="Link opens in new window - close new window to return to this page." /></a> released at the Future Energy Economy Summit in September. The Summit put forward actions and needs associated with the simultaneous advancement of economic growth and a zero-emission electricity system in New York State, addressing increasing energy demands due to new economic development opportunities, acceleration of renewable energy development, as well as advancement of the technologies that will be necessary to enable a deeply renewable grid.
In addition to the RFI and the Final Blueprint for Consideration of Advanced Nuclear Energy Technologies in progress, other actions underway to inform planning for future energy needs include:
<ul>
<li><a href="https://energyplan.ny.gov/">New York's State Energy Plan <img src="https://www.nyserda.ny.gov/-/media/Project/Common/General/Rest/new-window.gif" alt="Link opens in new window - close new window to return to this page." /></a> update process, which commenced in September 2024 and will address all parts of the New York energy sector; and</li>
<li>The Public Service Commission Proceeding on Motion of the Commission to Implement a Large-Scale Renewable Program and a Clean Energy Standard ("0x40") <a href="https://documents.dps.ny.gov/public/MatterManagement/CaseMaster.aspx?Mattercaseno=15-E-0302">NYSDPS-DMM: Matter Master <img src="https://www.nyserda.ny.gov/-/media/Project/Common/General/Rest/new-window.gif" alt="Link opens in new window - close new window to return to this page." /></a>, which focuses on pursuing the target of zero emissions in the electricity sector by 2040, as set out in the Climate Leadership and Community Protection Act.</li>
</ul>
Information gathered through the request announced today is considered advisory in nature and any action by NYSERDA will be subject to all applicable laws, including procedural, regulatory, and environmental review requirements.

OKLO

"Advanced Nuclear Technologies Request For Information Announced To Gauge Market Interest; Seeks To Identify Entities Pursuing Or Interested In Potential Role In Development Of Advanced Nuclear Energy In New York" - NYSERDA

TD Cowen analyst Yaron Werber maintains Ascendis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) with a Buy and lowers the price target from $160 to $153.

ASND

TD Cowen Maintains Buy on Ascendis Pharma, Lowers Price Target to $153

Janney Montgomery Scott analyst Timothy Coffey upgrades Hanmi Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAFC#NASDAQ">HAFC</a>) from Neutral to Buy.

Upgrades

HAFC

Janney Montgomery Scott Upgrades Hanmi Financial to Buy

<a href="https://www.wsj.com/business/media/investor-building-newspaper-chain-eyes-lee-enterprises-dallasnews-9f2c1f54">https://www.wsj.com/business/media/investor-building-newspaper-chain-eyes-lee-enterprises-dallasnews-9f2c1f54</a>
&nbsp;
A Florida billionaire with a fondness for local news is looking to build a newspaper giant by potentially scooping up publishers <a href="https://www.wsj.com/market-data/quotes/LEE">Lee Enterprises</a> and <a href="https://www.wsj.com/market-data/quotes/DALN">DallasNews</a>.
David Hoffmann, who last month disclosed a 5.2% stake in Lee Enterprises, has raised that interest to 8.7%, making him the Davenport, Iowa, company's second-largest shareholder.

DALN

'Investor Building Newspaper Chain Eyes Lee Enterprises, DallasNews; Florida Billionaire David Hoffmann Aims To Create The Second-Largest Newspaper Group In America' - WSJ

TD Cowen analyst Oliver Chen maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Hold and lowers the price target from $57 to $22.

CPRI

TD Cowen Maintains Hold on Capri Holdings, Lowers Price Target to $22

<a href="https://newsroom.snap.com/snap-os-v558">https://newsroom.snap.com/snap-os-v558</a>
For developers, we believe that camera access unlocks the full potential of AR. Today, we're launching Snap OS v5.58, which includes new Lenses that showcase the power of the Spectacles camera and SnapML, as well as platform features and capabilities to help you better build and experiment with Spectacles Lenses.
Introducing Piano Tutor and Ball Games
&nbsp;
The Piano Tutor Lens puts a personal instructor and interactive courses at your fingertips. Powered by SnapML, the Lens uses a custom machine learning model to identify and track a variety of pianos, overlaying notes onto the keys in real-time. This helps you build awareness of the keyboard layout and coordinate your movement accordingly. Using another custom ML model, the Lens can detect how well you play and provide real-time feedback.
The Ball Game Lens is a game that transforms a physical ball into a controller, making it easy and fun to practice your skills through a set of different challenges. Using a custom ML tracking model, the Lens follows the ball's movements, allowing you to interact with physical and digital elements together and master the perfect kick.
New Platform Features and APIs
&nbsp;
To unlock the ability to experiment further in development, we're introducing new APIs that make it easy to use camera data and multi-modal Large Language Models (LLMs) hosted in the cloud. Using extended permissions developer settings and our new Fetch API, you can now build Lenses that directly interface with hosted multi-modal LLMs.
We're also introducing an Image Spatialization API, which leverages generative AI to convert common 2D image formats into 3D. Developers can now incorporate this API into their Lenses to create stunning 3D effects with such realistic depth you'll feel like you're truly in the moment.&nbsp;
Additional platform capabilities include:
Spatial Anchors: Anchor digital objects to specific locations within a Lens and return to them later
Basic Location: Get access to the GPS coordinates of your Spectacles to create more realistic outdoor experiences
Layout Mode: Import images from your phone using the Spectacles app and spatialize them for a captivating 3D experience
Web View: Drag and drop embed web pages directly into your Lenses
Lens Unlock: Unlock a Lens that has been submitted to Spectacles, but hasn't yet been added to a category or Lens Explorer, by simply sharing the URL&nbsp;
 To experience these Lenses and start building using the new features, update to the latest version of Snap OS and the Spectacles App using <a href="https://support.spectacles.com/hc/en-us/articles/30214953982740-Updating?lang=en-US">these instructions</a>. We can't wait to see what you create!

SNAP

'Snap Introducing New Lenses, Platform Features, And Capabilities For Spectacles' - Snap Newsroom

Economist and news analyst Larry Kudlow could return to a role in the White House with the former National Economic Council Director being eyed for a role among Donald Trump's growing list of possible <a href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower">Cabinet nominees and advisors.</a>
What Happened: Kudlow, who is a Fox Business Network host, served as the<a href="https://www.benzinga.com/topic/larry-kudlow"> National Economic Council Director </a>for Trump from 2018 to 2021.
Kudlow is being eyed to return to the Trump administration after Trump's recent win in the<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> 2024 presidential election.</a>
The economist, who met with Trump recently at Mar-a-Lago, could be considered to lead the National Economic Council once again or for a role within the Treasury Department, as <a href="https://www.wsj.com/politics/larry-kudlow-economic-role-trump-cabinet-3af2a446?mod=hp_lead_pos2">reported </a>Friday by the Wall Street Journal.
Kudlow has remained in touch with Trump since leaving the White House and has spoken positively of the president-elect on Fox Business, leading to Trump allies supporting the economist&#8217;s return to a White House role, according to the report.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent111524">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Kudlow began his role as National Economic Council Director in April 2018 and remained in the role until the end of Trump's presidency. While other members of Trump's cabinet and administration left or got fired, Kudlow stayed. 
Reports of Kudlow being considered for a White House role comes as some Trump allies say there is a growing battle between several candidates like Howard Lutnick and Scott Bessent for economic roles in the Trump administration.
The campaigning for the role of Treasury secretary has upset Trump, according to the report, which could mean he goes a different direction in naming his new economic advisor and leadership picks.
Other names being considered for economic positions include Apollo Global Management CEO Marc Rowan and former U.S. trade representative Robert Lighthizer, the WSJ reported. 
The week has been full of several announcements from Trump on who he is planning to nominate for key White House roles once his term begins in January. More announcements are expected between now and then. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation">Matt Gaetz Is Trump&#8217;s Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation</a></li>
</ul>
Photo via Shutterstock.

Government

Politics

Larry Kudlow As Trump Economic Advisor? Fox Business Host Under Consideration For Return To White House

TD Cowen analyst John Kernan maintains TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) with a Buy and raises the price target from $125 to $130.

TD Cowen Maintains Buy on TJX Companies, Raises Price Target to $130

Grown Rogue International Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GRIN#CSE">GRIN</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GRUSF#OTC">GRUSF</a>) reported its third quarter 2024 results on Thursday for the three months ended Sept. 30, 2024.
"This was another exciting quarter for Grown Rogue with solid financial metrics showing the continued execution by our team in competitive markets against a backdrop of modest price compression," CEO Obie Strickler said. "We continue to see strong indoor production yields of craft-quality flower, retail buyer and consumer loyalty, and great initial reception and sell-through with our branded pre-rolls, including our newest brand Yeti."
<h3 class="wp-block-heading">Q3 2024 Financial Highlights</h3>
The comparison period for 2023 is the three months ended Oct. 31, 2023, due to the fiscal year-end change from Oct. 31 to Dec. 31. 
<ul>
<li>Revenue totaled $7 million, up 7% compared to $6.5 million in the fourth quarter of 2023.</li>
<li>Gross profit amounted to $3.9 million, a decrease from $4.4 million in Q4 2023, primarily due to lower margins in Oregon and pricing pressures.</li>
<li>Adjusted EBITDA was positive at $2.1 million, unchanged from the previous quarter. Its margin was 30%, down 210 basis points from the fourth quarter of 2023.</li>
<li>Operating cash flow was $1.21 million, down 24% from $1.5 million in the fourth quarter of 2023. The decrease was attributed to increased spending on the New Jersey market launch.</li>
<li>Operating expenses increased by 35% to $2.95 million due to higher selling, general and administrative expenses.</li>
<li>The net loss was $667,240, an improvement from the $2.01 million recorded in the same period last year.</li>
<li>Cash and cash equivalents totaled $5.6 million, down from $6.8 million as of Dec. 31, 2023.</li>
<li>Positive cash flow of $5.01 million for the quarter.</li>
<li>Total assets grew to $41.3 million, up from $29.6 million at year-end 2023.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40576446/grown-rogue-cannabis-reports-record-q2-revenue-and-adjusted-ebitda-nj-and-illinois-major-growth-">Grown Rogue Cannabis Reports Record Q2 Revenue And Adjusted EBITDA, NJ And Illinois Major Growth Drivers</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Other Business Highlights</h3>
In New Jersey, Grown Rogue announced competition of the company's first harvest in the state, with product drops expected in Dec. 2024. The company is optimistic about generating significant cash flow from this market.
It also announced the commencement of phase I operations in the Garden State, which includes roughly 8,000 square feet of flowering canopy that will produce 500-600 pounds of whole flower per month with sales anticipated in the fourth quarter of 2024.
In Illinois, phase II construction is progressing, with a target of 1,100 pounds of whole flower production per month once completed in mid-2025.
Subsequent to quarter-end, the company announced the termination of an advisory agreement with Vireo Growth Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VREOF#OTC">VREOF</a>).
<h3 class="wp-block-heading">Outlook</h3>
Grown Rogue said it will focus on its New Jersey and Illinois expansions as primary growth drivers for 2025.
Additionally, Phase II of the New Jersey operation is expected to be completed by mid-2025, with the Illinois project following later in the year.
<h3 class="wp-block-heading">GRUSF Price Action</h3>
Grown Rogue's shares traded 2.94% higher at 7 cents per share after the market close on Thursday afternoon.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41284994/grown-rogue-secures-800k-vireo-forfeits-4-5m-warrants-in-cannabis-shakeup-whats-next-for-both">Grown Rogue Secures $800K, Vireo Forfeits 4.5M Warrants In Cannabis Shakeup—What&#8217;s Next For Both?</a></li>
</ul>

Cannabis

Earnings

CSE:GRIN

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

GRUSF

VREOF

Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion

TD Cowen analyst Oliver Chen maintains Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) with a Hold and raises the price target from $13 to $14.

TD Cowen Maintains Hold on Sally Beauty Holdings, Raises Price Target to $14

Citius Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive agreements for the purchase of an aggregate of 12,000,000 shares of its common stock and accompanying warrants to purchase up to an aggregate of 12,000,000 shares of its common stock, at a purchase price of $0.25 per share and accompanying warrant in a registered direct offering. The warrants will have an exercise price of $0.25 per share, will be exercisable immediately upon issuance, and will expire five years from the initial exercise date.&nbsp; The closing of the offering is expected to occur on or about November 18, 2024, subject to the satisfaction of customary closing conditions.
H.C. Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.
The aggregate gross proceeds to the Company from the offering are expected to be $3 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering for general corporate purposes, including pre-clinical and clinical development of our product candidates and working capital and capital expenditures.

Offerings

CTXR

Citius Pharmaceuticals Entered Into Definitive Agreements For The Purchase Of An Aggregate Of 12M Shares Of Its Common Stock And Accompanying Warrants To Purchase Up To An Aggregate Of 12M Shares Of Its Common Stock, At A Purchase Price Of $0.25 Per Share And Accompanying Warrant In A $3M Registered Direct Offering

Whales with a lot of money to spend have taken a noticeably bullish stance on Expedia Group.
Looking at options history for Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $203,880 and 6, calls, for a total amount of $424,321.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $110.0 to $192.5 for Expedia Group over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Expedia Group stands at 475.71, with a total volume reaching 1,784.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Expedia Group, situated within the strike price corridor from $110.0 to $192.5, throughout the last 30 days.
<h3>Expedia Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731695489_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$21.5</td>
<td>$21.1</td>
<td>$21.5</td>
<td>$160.00</td>
<td>$107.6K</td>
<td>1.3K</td>
<td>151</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$21.95</td>
<td>$21.0</td>
<td>$21.28</td>
<td>$160.00</td>
<td>$106.4K</td>
<td>1.3K</td>
<td>51</td>
</tr>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$1.43</td>
<td>$0.72</td>
<td>$0.74</td>
<td>$172.50</td>
<td>$88.8K</td>
<td>54</td>
<td>1.2K</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$21.3</td>
<td>$21.05</td>
<td>$21.3</td>
<td>$160.00</td>
<td>$78.8K</td>
<td>1.3K</td>
<td>101</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$41.75</td>
<td>$40.25</td>
<td>$40.81</td>
<td>$140.00</td>
<td>$65.2K</td>
<td>1.3K</td>
<td>16</td>
</tr>
</tbody>
</table>

<h3>About Expedia Group</h3>
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2023 sales), air tickets (3%), rental cars, cruises, in-destination, and other (11%), and advertising revenue (6%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Having examined the options trading patterns of Expedia Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Expedia Group</h3>
<ul>
<li>With a volume of 719,408, the price of EXPE is down -1.06% at $180.33. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 83 days.</li>
</ul>
<h3>Expert Opinions on Expedia Group</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $173.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Expedia Group, targeting a price of $210. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for Expedia Group, targeting a price of $166. 
&#x2A; An analyst from Jefferies persists with their Hold rating on Expedia Group, maintaining a target price of $160. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Expedia Group with a target price of $153. 
&#x2A; An analyst from Wedbush persists with their Neutral rating on Expedia Group, maintaining a target price of $180. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Expedia Group options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

EXPE

Expedia Group Options Trading: A Deep Dive into Market Sentiment

Strong dollar stretches Americans' vacation money but there's a cost to the U.S. economy

Operational Challenges Limit The Altitude For Airline Travel As Demand Climbs

JETS: Despite Booming Demand, Airlines Still Struggle With Profitability

Summer travel: U.S. airport security screenings top 3M in a single day in new record

June U.S. Retail Sales Show Surprising Vigor

Retail Sales Excl. Autos And Gasoline Jump By Most In 18 Months, Push Up Atlanta Fed GDPNow To 2.5%

Travel ETFs: Riding The Wave Of Consumer Demand

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The pullbacks in some of the top <a href="https://investorplace.com/industries/consumer-discretionary/travel/cruise/">cruise stocks</a> are all buying opportunities.



Look at Royal Caribbean (NYSE:<a href="https://investorplace.com/stock-quotes/rcl-stock-quote/">RCL</a>), for example.



Even with strong booking demand and earnings growth, the stock dropped from about $173 to a recent low of about $152, where it&rsquo;s now oversold and pivoting higher. Not only did it just catch support at its 50-day moving average, but it&rsquo;s also excessively oversold on RSI and Williams&rsquo; %R. While expecting RCL to resume its uptrend, I&rsquo;d buy the temporary weakness.



From its last traded price of $157, I&rsquo;m looking for an initial retest of $173.&nbsp;



Helping, <a href="https://seekingalpha.com/news/4128143-royal-caribbean-cruises-non-gaap-eps-of-321-beats-by-046-revenue-of-411b-beats-by-60m-reinstates-dividend">RCL just raised its adjusted earnings per share</a> outlook to a new range of $11.35 to $11.45 from an older range of $10.70 to $10.90. The company even reinstated a 40-cent dividend, payable on Oct. 11. That, coupled with explosive demand makes Royal Caribbean a strong buy at current prices.



However, it&rsquo;s not just RCL that could rally to higher highs. Here are three more cruise stocks that could see plenty of smooth sailing ahead, too.



<h2>Carnival (CCL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/ccl1600-300x169.png" alt="Carnival (CCL) logo sign in the night at their headquarters in Miami, Florida, USA. Carnival Cruise Line is an international cruise line."><div>Source: JHVEPhoto / Shutterstock.com</div></div>Oversold at $17.12, Carnival (NYSE:<a href="https://investorplace.com/stock-quotes/ccl-stock-quote/">CCL</a>) is another one of the top cruise stocks to buy.



For one, the company managed to beat EPS estimates in each of its last seven quarters. Two, in its <a href="https://www.carnivalcorp.com/node/75226/pdf">most recent earnings report,</a> company bookings are at record highs this year and are significantly exceeding 2023 numbers. Three, CCL is already touting record bookings for 2025 as well.



Even better, the company saw customer deposits hit a record high of $8.3 billion in the second quarter, which was $1.1 billion higher than a prior record high.



Helping, over the last few days, JPMorgan (NYSE:<a href="https://investorplace.com/stock-quotes/jpm-stock-quote/">JPM</a>) raised its price target on CCL to $25 with a Buy rating. Analysts at Truist also raised their price target to $25 with a hold rating. In total, 14 <a href="https://www.tipranks.com/stocks/ccl/forecast">analysts rate CCL a buy.</a> Two have a Hold rating, and one has a Sell rating, which makes no sense. The average price target on CCL is currently $21.72.&nbsp;



<h2>Norwegian Cruise Line (NCLH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/nclh-1600-300x169.png" alt="Norwegian Cruise Line ship docked in Saint Petersburg. NCLH stock."><div>Source: Nazar Skladanyi / Shutterstock</div></div>Oversold at its 100-day moving average, Norwegian Cruise Line (NYSE:<a href="https://investorplace.com/stock-quotes/nclh-stock-quote/">NCLH</a>) is also a buy.



Just this morning, the company <a href="https://seekingalpha.com/news/4130981-norwegian-cruise-lines-earns-record-q2-revenue">posted beat</a> top and bottom line estimates. EPS of 40 cents beat by 6 cents. Revenue of $2.4 billion, up 8.6% year-over-year, beat by $20 million. Adjusted EBITDA jumped 14% to $587.7 million.&nbsp;



NCLH also raised its <a href="https://www.nclhltd.com/news-media/press-releases/detail/620/norwegian-cruise-line-holdings-reports-strong-second">full-year adjusted</a> net income guidance by $60 million to about $790 million from $730 million. It also increased its adjusted EPS guidance to $1.53 from $1.42.




Better, <a href="https://seekingalpha.com/news/4130981-norwegian-cruise-lines-earns-record-q2-revenue">according to CEO Harry Sommer,</a> &ldquo;The momentum we are garnering from strong yield growth, disciplined cost&nbsp;management and the initiatives that comprise our Charting the Course strategy further bolsters our confidence in achieving our previously announced 2026 financial and sustainability targets.&rdquo;&nbsp;




I&rsquo;d also use recent weakness as a buying opportunity with NCLH, too. With patience, I&rsquo;d like to see the stock rally back to $21.50 initially.



<h2>Defiance Hotel, Airline and Cruise ETF (CRUZ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/06/cruise-stocks1600-300x169.png" alt="Tourist girl with backpack and hat standing in front of big cruise liner. Cruise stocks"><div>Source: Zigres / Shutterstock.com</div></div>Or, if you&rsquo;d rather diversify at a lower cost, there&rsquo;s the exchange-traded fund&nbsp;Defiance Hotel, Airline, and Cruise (NYSEARCA:<a href="https://investorplace.com/stock-quotes/cruz-stock-quote/">CRUZ</a>). After catching strong support at $21 dating back to February, it&rsquo;s also a buy, as it just starts to pivot higher. Last trading at $21.31, I&rsquo;d like to see it initially retest $22.40.



With an expense ratio of 0.45%, the CRUZ ETF holds 63 top cruise, hotel and <a href="https://investorplace.com/industries/consumer-discretionary/travel/airline/"></a>airline stocks, including Hilton Worldwide (NYSE:<a href="https://investorplace.com/stock-quotes/hlt-stock-quote/">HLT</a>), Marriott (NASDAQ:<a href="https://investorplace.com/stock-quotes/mar-stock-quote/">MAR</a>), Royal Caribbean, Carnival, Delta Air Lines (NYSE:<a href="https://investorplace.com/stock-quotes/dal-stock-quote/">DAL</a>) and Southwest Airlines (NYSE:<a href="https://investorplace.com/stock-quotes/luv-stock-quote/">LUV</a>) &mdash; to name a few of the top holdings.&nbsp;Not only do you get exposure to top cruise stocks but also some of the best hotel and&nbsp;airline stocks &mdash; all for less than $22 a share at the moment.



With the CRUZ ETF, I&rsquo;d use the recent, temporary weakness as a buying opportunity.



On the date of publication, Ian Cooper&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned.&nbsp;The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines.</a>



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Ian Cooper, a contributor to InvestorPlace.com, has been analyzing stocks and options for web-based advisories since 1999.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/07/the-top-3-cruise-stocks-to-buy-now-summer-2024/">The Top 3 Cruise Stocks to Buy Now: Summer 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The Top 3 Cruise Stocks to Buy Now: Summer 2024

This Or That: ETF Themes Edition

What Trump's Win May Mean For The Markets And Economy

AGNG

ARKG

ARKK

AWAY

BBRE

BEDZ

BMED

BNGE

CNCR

CORN

CPCAF

CPCAY

DLAKF

EATV

EATZ

EBIZ

EDOC

FDIS

FHLC

FIDU

FREL

FSTA

FTAG

FTXG

FTXH

FTXR

GGME

GNOM

HART

HELX

HTEC

IBBQ

IBUY

ICAGY

IDNA

IEDI

IPAV

ISHP

IVEG

JETS

JJATF

JJGTF

JJMTF

JRNY

KBWY

KROP

LABU

LUXX

MADE

MDEV

NCLH

ONLN

OOTO

PAVE

PILL

PINK

PPTY

PSCC

PSCD

PSCH

QABSY

QUBSF

REIT

RSHO

RSPD

RSPH

RSPN

RSPS

RYAAY

RYAOF

SBIO

SCHH

SEVN

SOYB

SRVR

USDU

USRT

VEGI

VRAI

WDNA

WZZAF

WZZZY

XLRE

로얄 캐리비안 크루즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>)의 주가가 화요일에 혼재된 <a href="https://www.benzinga.com/news/earnings/24/10/41601688/royal-caribbean-eyes-14-eps-in-2025-amid-cruise-demand-and-expanded-destinations" target="_blank" rel="noreferrer noopener">3분기 실적을 발표</a> 후 3% 이상 상승했다.
매출은 전년 대비 17.5% 증가한 48억 9천만 달러로, 컨센서스인 49억 달러를 밑돌았고, 조정된 주당순이익(EPS)은 5.20 달러로 <a href="https://www.benzinga.com/news/earnings/24/10/41601688/royal-caribbean-eyes-14-eps-in-2025-amid-cruise-demand-and-expanded-destinations" target="_blank" rel="noreferrer noopener">컨센서스인 5.03 달러를 상회</a>했다.
이 회사는 4분기 순수익률이 5.1%에서 5.6% 증가할 것으로 예상하고 있으며, 조정된 EPS는 1.40–1.45 달러로 <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">예상 EPS인 2.28 달러에 미치지 못할 것</a>으로 보인다.
골드만삭스의 애널리스트인 리지 도브(Lizzie Dove)는 앞으로의 전망에서 주요 실망 요인이 4분기 가이던스에서 나타날 것으로 예상한다고 작성했다. 보고된 순수익률 성장률은 5.3%에서 5.8%로 예상되며, 이는 예상치인 5.9%보다 약간 낮다.
이 전망은 허리케인 밀턴의 영향(약 40베이시스포인트로 추정)을 이미 반영한 것으로, 중간값을 5.95%로 조정한다고 애널리스트는 덧붙였다.
또한, 도브는 비용에 대한 강조가 증가할 것으로 예상하며, 4분기 가이던스의 연간 보고된 성장률이 7.8%에서 8.3%로 골드만삭스 및 시장 예상치인 5.6%에서 5.8%를 초과한다고 언급했다.
이 애널리스트는 4분기 조정 EPS 가이던스가 0.24 달러의 악재를 포함하고 있다고 말하며, 이는 허리케인 밀턴으로 인한 1/3과 3분기에서의 비용 전환 시기 조정 및 비현금 주식 보상 증가로 인한 2/3라고 설명했다.
3분기에서의 비용 전환 시점 조정을 반영하면 EPS 초과 달성이 감소하여 투자자 기대에 미치지 못할 수 있다고 이 애널리스트가 덧붙였다.
하지만, 도브는 기본적인 수치는 여전히 견고하다고 말하며, 수요와 가격 조건이 지난 실적 발표 이후 개선되었고 2025년에는 강한 수요가 예상된다고 강조했다.
이 애널리스트는 이러한 결과로 인해 시장의 장기 추정치가 상승할 것으로 예상하며, 현재 2025년 EPS가 14.04 달러로 추정되고, 시장의 추정치는 13.70 달러라고 언급했다.
투자자들은 Defiance Hotel, Airline, and Cruise ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRUZ#NYSE">CRUZ</a>)와 Invesco Leisure and Entertainment ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEJ#NYSE">PEJ</a>)를 통해 이 주식에 접근할 수 있다.
주가 움직임: 화요일 로얄 캐리비안의 주식이 3.23% 상승하여 210.10달러에 마감되었다.
이미지 제공: Unsplash
다음 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ED%81%AC%EB%A3%A8%EC%A6%88-%EB%9D%BC%EC%9D%B8%EC%9D%80-sp-500%EC%97%90%EC%84%9C-10%EC%9B%94-%EC%B5%9C%EA%B3%A0%EC%9D%98-%EC%84%B1%EA%B3%BC-%EB%A1%9C%EC%96%84-%EC%BA%90%EB%A6%AC%EB%B9%84/" target="_blank" rel="noopener">크루즈 라인이 S&amp;P 500의 10월 최고의 실적 주식 중 하나: 로얄 캐리비안과 노르웨이안 실적이 모멘텀을 유지할 수 있을까?</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Defiance Hotel, Airline, and Cruise ETF

뉴스

에 대한 최신 뉴스 Defiance Hotel, Airline, and Cruise ETF (ARCA:CRUZ)

수요일, 10월 30, 2024

뉴스

파트너 / 기고자

벤징가 글로벌